vs
Side-by-side financial comparison of AmpliTech Group, Inc. (AMPG) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $4.5M, roughly 1.2× AmpliTech Group, Inc.). AmpliTech Group, Inc. runs the higher net margin — -71.6% vs -507.8%, a 436.1% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 141.6%). Over the past eight quarters, AmpliTech Group, Inc.'s revenue compounded faster (39.7% CAGR vs 26.8%).
Ampli Energy is a South African company providing a renewable energy trading platform that uses a wheeling process to deliver green energy to consumers.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
AMPG vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.5M | $5.5M |
| Net Profit | $-3.2M | $-27.9M |
| Gross Margin | 22.8% | — |
| Operating Margin | -73.3% | -516.0% |
| Net Margin | -71.6% | -507.8% |
| Revenue YoY | 141.6% | 171.3% |
| Net Profit YoY | 16.1% | -48.3% |
| EPS (diluted) | $-0.14 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.5M | $5.5M | ||
| Q3 25 | $6.1M | $0 | ||
| Q2 25 | $11.0M | $2.0M | ||
| Q1 25 | $3.6M | $2.3M | ||
| Q4 24 | $1.9M | $2.0M | ||
| Q3 24 | $2.8M | $1.8M | ||
| Q2 24 | $2.5M | $1.1M | ||
| Q1 24 | $2.3M | $3.4M |
| Q4 25 | $-3.2M | $-27.9M | ||
| Q3 25 | $-188.4K | $-32.7M | ||
| Q2 25 | $-1.8M | $-26.9M | ||
| Q1 25 | $-1.8M | $-21.5M | ||
| Q4 24 | $-3.8M | $-18.8M | ||
| Q3 24 | $-1.2M | $-25.5M | ||
| Q2 24 | $-1.6M | $-20.9M | ||
| Q1 24 | $-4.7M | $-24.1M |
| Q4 25 | 22.8% | — | ||
| Q3 25 | 48.6% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 33.0% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 47.6% | — | ||
| Q2 24 | 41.8% | — | ||
| Q1 24 | 38.5% | — |
| Q4 25 | -73.3% | -516.0% | ||
| Q3 25 | -3.6% | — | ||
| Q2 25 | -17.5% | -1347.1% | ||
| Q1 25 | -52.5% | -930.5% | ||
| Q4 24 | -234.5% | -985.8% | ||
| Q3 24 | -38.4% | -1448.4% | ||
| Q2 24 | -62.0% | -1915.4% | ||
| Q1 24 | -62.3% | -713.3% |
| Q4 25 | -71.6% | -507.8% | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -16.1% | -1353.6% | ||
| Q1 25 | -51.1% | -935.2% | ||
| Q4 24 | -206.2% | -929.0% | ||
| Q3 24 | -42.0% | -1427.5% | ||
| Q2 24 | -62.4% | -1882.0% | ||
| Q1 24 | -203.0% | -705.4% |
| Q4 25 | $-0.14 | $-0.08 | ||
| Q3 25 | $-0.01 | $-0.09 | ||
| Q2 25 | $-0.09 | $-0.09 | ||
| Q1 25 | $-0.09 | $-0.08 | ||
| Q4 24 | $-0.28 | $-0.07 | ||
| Q3 24 | $-0.12 | $-0.10 | ||
| Q2 24 | $-0.16 | $-0.09 | ||
| Q1 24 | $-0.48 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $32.9M | $246.9M |
| Total Assets | $51.5M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $319.8M | ||
| Q3 25 | $8.4M | $297.3M | ||
| Q2 25 | $11.1M | $312.8M | ||
| Q1 25 | $16.9M | $116.6M | ||
| Q4 24 | $19.3M | $139.0M | ||
| Q3 24 | $1.1M | $157.7M | ||
| Q2 24 | $1.0M | $172.7M | ||
| Q1 24 | $2.4M | $124.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $36.4K | — | ||
| Q1 24 | $63.2K | — |
| Q4 25 | $32.9M | $246.9M | ||
| Q3 25 | $35.8M | $219.0M | ||
| Q2 25 | $35.8M | $248.7M | ||
| Q1 25 | $35.8M | $55.1M | ||
| Q4 24 | $37.5M | $71.5M | ||
| Q3 24 | $20.4M | $88.8M | ||
| Q2 24 | $20.7M | $108.9M | ||
| Q1 24 | $22.2M | $53.8M |
| Q4 25 | $51.5M | $343.3M | ||
| Q3 25 | $47.2M | $316.6M | ||
| Q2 25 | $48.6M | $333.3M | ||
| Q1 25 | $42.1M | $138.4M | ||
| Q4 24 | $43.2M | $160.4M | ||
| Q3 24 | $27.5M | $180.2M | ||
| Q2 24 | $25.4M | $200.4M | ||
| Q1 24 | $26.9M | $153.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.4M | $-26.7M |
| Free Cash FlowOCF − Capex | $-3.5M | — |
| FCF MarginFCF / Revenue | -78.4% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.4M | $-26.7M | ||
| Q3 25 | $-999.4K | $-24.2M | ||
| Q2 25 | $-2.3M | $-20.2M | ||
| Q1 25 | $-2.0M | $-22.0M | ||
| Q4 24 | $-1.2M | $-18.3M | ||
| Q3 24 | $-1.7M | $-21.6M | ||
| Q2 24 | $-1.3M | $-21.5M | ||
| Q1 24 | $-1.1M | $-19.8M |
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-1.4M | $-24.3M | ||
| Q2 25 | $-2.4M | — | ||
| Q1 25 | $-2.4M | — | ||
| Q4 24 | $-1.2M | $-18.3M | ||
| Q3 24 | $-1.7M | $-21.6M | ||
| Q2 24 | $-1.3M | $-21.7M | ||
| Q1 24 | $-1.1M | $-19.9M |
| Q4 25 | -78.4% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -21.6% | — | ||
| Q1 25 | -65.8% | — | ||
| Q4 24 | -63.9% | -905.5% | ||
| Q3 24 | -61.6% | -1210.9% | ||
| Q2 24 | -52.7% | -1951.9% | ||
| Q1 24 | -47.0% | -584.5% |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 7.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 0.9% | 0.1% | ||
| Q3 24 | 0.4% | 2.0% | ||
| Q2 24 | 0.5% | 18.1% | ||
| Q1 24 | 0.1% | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMPG
| Other | $2.7M | 60% |
| Distribution | $1.8M | 40% |
TSHA
Segment breakdown not available.
